Chemical Structure : ATWLPPR peptide TFA
CAS No.:
货号: PC-27814Not For Human Use, Lab Use Only.
ATWLPPR peptide TFA (A7R, Ala-Thr-Trp-Leu-Pro-Pro-Arg) is a specific NRP-1 (Neuropilin 1, NRP1) inhibitor and effective antagonist of the VEGF165 binding to NRP-1 with IC50 of 5.9 uM blocks vascular endothelial growth factor (VEGF)-mediated angiogenesis.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥880 | In stock | |
| 10 mg | ¥1280 | In stock | |
| 25 mg | ¥1980 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
ATWLPPR peptide TFA (A7R, Ala-Thr-Trp-Leu-Pro-Pro-Arg) is a specific NRP-1 (Neuropilin 1, NRP1) inhibitor and effective antagonist of the VEGF165 binding to NRP-1 with IC50 of 5.9 uM blocks vascular endothelial growth factor (VEGF)-mediated angiogenesis.
ATWLPPR completely abolished VEGF binding to cell-displayed kinase domain receptor (KDR/FLK1 or VEGFR-2).
ATWLPPR inhibits VEGF-mediated proliferation of human vascular endothelial cells, in a dose-dependent and endothelial cell type-specific manner.
ATWLPPR totally abolishes VEGF-induced angiogenesis in a rabbit corneal model.
| 分子量 | 954.00 | |
| 分子式 | C42H62F3N11O11 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
Ala-Thr-Trp-Leu-Pro-Pro-Arg TFA salt |
|
1. Binétruy-Tournaire R, et al. EMBO J. 2000 Apr 3;19(7):1525-33.
2. Rodrigues S, et al. FASEB J. 2003 Jan;17(1):7-16.
3. Tymecka D, et al. Eur J Med Chem. 2018 Oct 5;158:453-462.
4. Starzec A, et al. Peptides. 2007 Dec;28(12):2397-402.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright